[The ISAR-SAFE study]

G Ital Cardiol (Rome). 2015 Jun;16(6):331-5. doi: 10.1714/1934.21024.

[Article in Italian]

Authors

Piera Capranzano¹, Battistina Castiglioni²

Affiliations

¹ Dipartimento Cardiovascolare, Ospedale Ferrarotto, Università degli Studi di Catania.
² Cardiologia Interventistica, U.O. Cardiologia 2, Dipartimento Cardiovascolare, A.O. Ospedale di Circolo di Varese.

PMID: 26156693
DOI: 10.1714/1934.21024

No abstract available

Publication types

Comparative Study

MeSH terms

Aspirin / adverse effects
Aspirin / therapeutic use*
Cardiovascular Diseases / prevention & control
Clopidogrel
Coronary Disease / drug therapy
Coronary Disease / surgery*
Coronary Restenosis / etiology
Coronary Restenosis / prevention & control
Drug Administration Schedule
Drug-Eluting Stents* / adverse effects
Humans
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use*
Postoperative Complications / etiology
Postoperative Complications / prevention & control*
Purinergic P2Y Receptor Antagonists / adverse effects
Purinergic P2Y Receptor Antagonists / therapeutic use*
Randomized Controlled Trials as Topic / methods
Research Design
Risk
Thrombosis / etiology
Thrombosis / prevention & control*
Ticlopidine / adverse effects
Ticlopidine / analogs & derivatives*
Ticlopidine / therapeutic use

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Clopidogrel
Ticlopidine
Aspirin